Contact Dermatitis Clinical Trial
Official title:
Testing the Effectiveness of an Intervention in Irritative Contact Dermatitis:Randomized Controlled Trial
An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system.
An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system. Therefore, the aim of this study was to see if omega cream, as proposed by its mechanism of action, could improve SLS induced contact dermatitis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00371163 -
Molecular and Cellular Characterization of Spongiotic Dermatitis
|
N/A | |
| Completed |
NCT02028208 -
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
|
Phase 2 | |
| Not yet recruiting |
NCT04853823 -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
|
Phase 1 | |
| Recruiting |
NCT06387472 -
DermAI to Evaluate Human Factor of Testing
|
N/A | |
| Completed |
NCT02700373 -
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03089775 -
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
|
Phase 1 | |
| Completed |
NCT04438135 -
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
|
N/A | |
| Completed |
NCT04921163 -
Children With Aluminium Contact Allergy: Oral Exposure Study
|
N/A | |
| Not yet recruiting |
NCT02026700 -
Bariederm Cream in Chronic Contact Dermatitis
|
N/A | |
| Completed |
NCT02028182 -
Clinical Evaluation of Lyral® Dose Response Study
|
Phase 2 | |
| Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A | |
| Completed |
NCT00646867 -
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
|
N/A | |
| Withdrawn |
NCT01518348 -
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
|
Phase 3 | |
| Recruiting |
NCT03705182 -
Prevention of Dermatitis in Epoxy Exposed Workers
|
N/A | |
| Terminated |
NCT03198390 -
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
|
||
| Completed |
NCT00614289 -
Novel Topical Treatment of Hand Dermatitis (Eczema)
|
Phase 1 | |
| Recruiting |
NCT06331390 -
Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
|
N/A | |
| Completed |
NCT00640250 -
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
|
Phase 2 | |
| Completed |
NCT00640614 -
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
|
Phase 3 | |
| Recruiting |
NCT06177314 -
Molecular Diagnosis of Allergic Contact Dermatitis
|